α-Synuclein structures from fluorescence energy-transfer kinetics: Implications for the role of the protein in Parkinson's disease
暂无分享,去创建一个
Harry B. Gray | Jay R. Winkler | Ralf Langen | Jennifer C. Lee | H. Gray | J. Winkler | R. Langen | Patrick Hummel | Patrick Hummel
[1] Olaf Riess,et al. AlaSOPro mutation in the gene encoding α-synuclein in Parkinson's disease , 1998, Nature Genetics.
[2] P J McLean,et al. Membrane association and protein conformation of alpha-synuclein in intact neurons. Effect of Parkinson's disease-linked mutations. , 2000, The Journal of biological chemistry.
[3] F. Poulsen,et al. Time-resolved fluorescence studies of the molten globule state of apomyoglobin. , 1996, Journal of molecular biology.
[4] P. S. St George-Hyslop,et al. α-Synuclein Membrane Interactions and Lipid Specificity* , 2000, The Journal of Biological Chemistry.
[5] T. Dawson,et al. Molecular Pathways of Neurodegeneration in Parkinson's Disease , 2003, Science.
[6] Graham R. Fleming,et al. Subpicosecond fluorescence anisotropy studies of tryptophan in water , 1990 .
[7] J. Parkinson. An Essay on the Shaking Palsy , 2002 .
[8] R. Perrin,et al. Interaction of human alpha-Synuclein and Parkinson's disease variants with phospholipids. Structural analysis using site-directed mutagenesis. , 2000, The Journal of biological chemistry.
[9] P. Lansbury,et al. Annular alpha-synuclein protofibrils are produced when spherical protofibrils are incubated in solution or bound to brain-derived membranes. , 2002, Biochemistry.
[10] D. Eliezer,et al. A structural and functional role for 11-mer repeats in alpha-synuclein and other exchangeable lipid binding proteins. , 2003, Journal of molecular biology.
[11] P. V. von Hippel,et al. Calculation of protein extinction coefficients from amino acid sequence data. , 1989, Analytical biochemistry.
[12] A. Jonas,et al. Nanosecond rotational motions of apolipoprotein C-I in solution and in complexes with dimyristoylphosphatidylcholine. , 1982, Biochemistry.
[13] William H. Press,et al. Numerical recipes , 1990 .
[14] R. Scheller,et al. Synuclein: a neuron-specific protein localized to the nucleus and presynaptic nerve terminal , 1988, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[15] A. Jonas,et al. Stabilization of α-Synuclein Secondary Structure upon Binding to Synthetic Membranes* , 1998, The Journal of Biological Chemistry.
[16] D. Eliezer,et al. Residual Structure and Dynamics in Parkinson's Disease-associated Mutants of α-Synuclein* , 2001, The Journal of Biological Chemistry.
[17] Christopher G. Adda,et al. Interaction of the Molecular Chaperone αB-Crystallin with α-Synuclein: Effects on Amyloid Fibril Formation and Chaperone Activity , 2004 .
[18] S. L. Mayo,et al. DREIDING: A generic force field for molecular simulations , 1990 .
[19] Alexander D. MacKerell,et al. All-atom empirical potential for molecular modeling and dynamics studies of proteins. , 1998, The journal of physical chemistry. B.
[20] Akihiko Iwai,et al. The precursor protein of non-Aβ component of Alzheimer's disease amyloid is a presynaptic protein of the central nervous system , 1995, Neuron.
[21] David F. Clayton,et al. The synucleins: a family of proteins involved in synaptic function, plasticity, neurodegeneration and disease , 1998, Trends in Neurosciences.
[22] Ralf Langen,et al. Structure of membrane-bound α-synuclein studied by site-directed spin labeling , 2004 .
[23] Sharon Brunett,et al. Molecular dynamics for very large systems on massively parallel computers: The MPSim program , 1997 .
[24] S. P. Moulik,et al. Thermodynamics of Micelle Formation of Ionic Surfactants: A Critical Assessment for Sodium Dodecyl Sulfate, Cetyl Pyridinium Chloride and Dioctyl Sulfosuccinate (Na Salt) by Microcalorimetric, Conductometric, and Tensiometric Measurements , 2001 .
[25] P. S. St George-Hyslop,et al. Defective membrane interactions of familial Parkinson's disease mutant A30P α-synuclein , 2002 .
[26] Jennifer C. Lee,et al. Structural features of cytochrome c′ folding intermediates revealed by fluorescence energy-transfer kinetics , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[27] Michel Goedert,et al. Identification of two distinct synucleins from human brain , 1994, FEBS letters.
[28] P. Lansbury,et al. Vesicle permeabilization by protofibrillar alpha-synuclein is sensitive to Parkinson's disease-linked mutations and occurs by a pore-like mechanism. , 2002, Biochemistry.
[29] M. L. Schmidt,et al. α-Synuclein in Lewy bodies , 1997, Nature.
[30] D. Eliezer,et al. Conformational properties of alpha-synuclein in its free and lipid-associated states. , 2001, Journal of molecular biology.
[31] J M Beechem,et al. Simultaneous determination of intramolecular distance distributions and conformational dynamics by global analysis of energy transfer measurements. , 1989, Biophysical journal.
[32] J M Beechem,et al. Time-resolved fluorescence of proteins. , 1985, Annual review of biochemistry.
[33] L. Brand,et al. Resonance energy transfer: methods and applications. , 1994, Analytical biochemistry.
[34] B. Vallee,et al. [44] Nitration with tetranitromethane. , 1972, Methods in enzymology.
[35] M. Goedert,et al. Binding of α-Synuclein to Brain Vesicles Is Abolished by Familial Parkinson’s Disease Mutation* , 1998, The Journal of Biological Chemistry.
[36] Peter T. Lansbury,et al. Accelerated in vitro fibril formation by a mutant α-synuclein linked to early-onset Parkinson disease , 1998, Nature Medicine.
[37] W. Press,et al. Numerical Recipes Example Book (C). , 1989 .
[38] A. Helenius,et al. Solubilization of membranes by detergents. , 1975, Biochimica et biophysica acta.
[39] Robert L. Nussbaum,et al. Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease , 1997 .
[40] Anders Björklund,et al. Prospects for new restorative and neuroprotective treatments in Parkinson's disease , 1999, Nature.
[41] G. Withers,et al. Delayed localization of synelfin (synuclein, NACP) to presynaptic terminals in cultured rat hippocampal neurons. , 1997, Brain research. Developmental brain research.
[42] M. Volkenstein,et al. Statistical mechanics of chain molecules , 1969 .
[43] L. Forno,et al. Neuropathology of Parkinson's Disease , 1996, Journal of neuropathology and experimental neurology.
[44] S. Georghiou,et al. Melittin-phospholipid interaction studied by employing the single tryptophan residue as an intrinsic fluorescent probe. , 1982, Biochimica et biophysica acta.
[45] A. Schober,et al. Genes, proteins, and neurotoxins involved in Parkinson’s disease , 2004, Progress in Neurobiology.
[46] David F. Clayton,et al. Characterization of a novel protein regulated during the critical period for song learning in the zebra finch , 1995, Neuron.
[47] G. Bignami. From entropy to Duino , 1999, Nature.
[48] V. Uversky,et al. Evidence for a Partially Folded Intermediate in α-Synuclein Fibril Formation* , 2001, The Journal of Biological Chemistry.
[49] H. Scheraga,et al. Distributions of intramolecular distances in the reduced and denatured states of bovine pancreatic ribonuclease A. Folding initiation structures in the C-terminal portions of the reduced protein. , 2001, Biochemistry.
[50] R. Anthony Crowther,et al. Synthetic filaments assembled from C‐terminally truncated α‐synuclein , 1998 .
[51] D. Marsh,et al. Alpha-synuclein association with phosphatidylglycerol probed by lipid spin labels. , 2003, Biochemistry.
[52] E. Zamrini,et al. Apoptotic-like changes in Lewy-body-associated disorders and normal aging in substantia nigral neurons. , 1997, The American journal of pathology.
[53] L. Thal,et al. Expression Pattern of Synucleins (Non‐Aβ Component of Alzheimer's Disease Amyloid Precursor Protein/α‐Synuclein) During Murine Brain Development , 1998 .
[54] M. Citron,et al. Both Familial Parkinson’s Disease Mutations Accelerate α-Synuclein Aggregation* , 1999, The Journal of Biological Chemistry.
[55] J Q Trojanowski,et al. Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies. , 1998, The American journal of pathology.
[56] W. Hill,et al. Contribution of somal Lewy bodies to neuronal death , 1997, Brain Research.
[57] T. Dawson. New Animal Models for Parkinson's Disease , 2000, Cell.
[58] J. Lakowicz. Principles of fluorescence spectroscopy , 1983 .
[59] Julia G. Lyubovitsky,et al. Structural features of the cytochrome C molten globule revealed by fluorescence energy transfer kinetics. , 2002, Journal of the American Chemical Society.
[60] P. Lansbury,et al. NACP, a protein implicated in Alzheimer's disease and learning, is natively unfolded. , 1996, Biochemistry.
[61] Jie Li,et al. The Association of α-Synuclein with Membranes Affects Bilayer Structure, Stability, and Fibril Formation* , 2003, Journal of Biological Chemistry.
[62] Reinhard Jahn,et al. A Broken α-Helix in Folded α-Synuclein* , 2003, The Journal of Biological Chemistry.
[63] M. Beal,et al. Experimental models of Parkinson's disease , 2001, Nature Reviews Neuroscience.
[64] P. Lansbury,et al. Acceleration of oligomerization, not fibrillization, is a shared property of both alpha-synuclein mutations linked to early-onset Parkinson's disease: implications for pathogenesis and therapy. , 2000, Proceedings of the National Academy of Sciences of the United States of America.